Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mirum Pharmaceuticals, Inc.

42.03
-1.2000-2.78%
Post-market: 42.030.00000.00%17:11 EDT
Volume:641.60K
Turnover:26.95M
Market Cap:2.06B
PE:-22.71
High:43.03
Open:42.15
Low:41.31
Close:43.23
Loading ...
Aug 06, 2020

Major Issues Report

8-K - Current report
Jun 16, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Apr 29, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Mar 12, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 17, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jan 14, 2020

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
Jan 06, 2020

Correspondence

[Cover]Correspondence
Jan 06, 2020

Correspondence

[Cover]Correspondence
Jan 06, 2020

Public Prospectus

General form for registration of securities under the Securities Act of 1933
Dec 27, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Dec 16, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Nov 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Sep 10, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals